Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. rallied 3.1% to $203.46 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.

Moderna Inc. hit a new 52-week high, surpassing its previous peak of $202.67, which the company achieved on September 25th.

The stock outperformed some of its peers, as Johnson & Johnson fell 1.6% to $267.57, Pfizer Inc. remained unchanged, and Gilead Sciences Inc. fell 0.61% to $151.28.

Trading volume totaled 13.1 million, compared to the 50-day average of 19.2 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 29, 2026 16:35 ET (20:35 GMT)